| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |